Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 143

Trial Status

Completed42
Terminated1

Role Distribution

Principal Investigator43
PI Rate100%

Activity Timeline

Clinical Trials (20)

Showing 10 of 20 trials

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Therapeutic Areas

Affiliations

Kendle International Inc.

Similar Key Opinion Leaders

Publications (0)

No publications found for this investigator.

Clinical Trials (43)

Showing 20 of 43 trials

NCT00647634Phase 1PrincipalInvestigator

Fasting Study of Alprazolam Extended-Release Tablets 3 mg to Xanax XR® Tablets 3 mg

Healthy
Completed
NCT00647686Phase 1PrincipalInvestigator

Bioequivalence and Wear Study of Mylan Fentanyl Transdermal System 25 µg/h and Mylan Fentanyl Transdermal System With Askina Derm Overlay

Healthy
Completed
NCT00647751Phase 1PrincipalInvestigator

Food Study of Lamotrigine Tablets 25 mg to Lamictal® Tablets 25 mg

Healthy
Completed
NCT00647842Phase 1PrincipalInvestigator

Bioequivalence and Wear Study of Mylan Fentanyl Transdermal System 25 µg/h and Mylan Fentanyl Transdermal System

Healthy
Completed
NCT00647894Phase 1PrincipalInvestigator

Fasting Study of Alprazolam Extended-Release Tablets 1 mg to Xanax XR Tablets 1 mg

Healthy
Completed
NCT00647959Phase 1PrincipalInvestigator

Fasting Study of Doxycycline Monohydrate Tablets 150 mg and Adoxa Tablets 150 mg

Healthy
Completed
NCT00648180Phase 1PrincipalInvestigator

Food Study of Doxycycline Monohydrate Tablets 100 mg and Adoxa Tablets 100 mg

Healthy
Completed
NCT00648414Phase 1PrincipalInvestigator

Study of the Effect of Clinical Procedures on Drug Delivery of Mylan Fentanyl Transdermal System 25 µg/hr and Duragesic® 25 µg/hr

Healthy
Terminated
NCT00648466Phase 1PrincipalInvestigator

Fasting Study of Sumatriptan Succinate Tablets 100 mg to Imitrex® Tablets 100 mg

Healthy
Completed
NCT00648570Phase 1PrincipalInvestigator

Fasting Study of Escitalopram Oxalate Tablets 20 mg and Lexapro® Tablets 20 mg

Healthy
Completed
NCT00648661Phase 1PrincipalInvestigator

Food Study of Escitalopram Oxalate Tablets 20 mg to Lexapro® Tablets 20 mg

Healthy
Completed
NCT00648791Phase 1PrincipalInvestigator

Fasting Study of Finasteride Tablets 5 mg and Proscar Tablets 5 mg

Healthy
Completed
NCT00648804Phase 1PrincipalInvestigator

Food Study of Ondansetron Orally Disintegrating Tablets 8 mg to Zofran ODT® Tablets 8 mg

Healthy
Completed
NCT00648934Phase 1PrincipalInvestigator

Fed Study of Topiramate Sprinkle Capsules 25 mg and Topamax® Sprinkle Capsules 25 mg

Healthy
Completed
NCT00648947Phase 1PrincipalInvestigator

Fasting Study of Clopidogrel Bisulfate Tablets 75 mg to Plavix® Tablets 75 mg

Healthy
Completed
NCT00649077Phase 1PrincipalInvestigator

Fasting Study of Meloxicam Tablets 15 mg and Mobic® Tablets 15 mg

Healthy
Completed
NCT00649155Phase 1PrincipalInvestigator

Fasting Study of Ciprofloxacin Extended-Release Tablets 500 mg and Cipro® XR Tablets 500 mg

Healthy
Completed
NCT00649363Phase 1PrincipalInvestigator

Fasting Study of Ondansetron Orally Disintegrating Tablets 8 mg to Zofran ODT® Tablets 8 mg

Healthy
Completed
NCT00649402Phase 1PrincipalInvestigator

Fed Study of Amlodipine and Benazepril HCl Capsules 10 mg/20 mg to Lotrel® Capsules 10 mg/20 mg

Healhty
Completed
NCT00649467Phase 1PrincipalInvestigator

Applesauce Study of Topiramate Sprinkle Capsules 25 mg and Topamax® Sprinkle Capsules 25 mg

Healthy
Completed